Abpro Holdings, Inc.
Abpro Holdings, Inc., a biotechnology company, focuses on novel antibody constructs for immuno-oncology and ophthalmology. Its platforms include DiversImmune, a discovery platform that generates a diverse collection of proprietary antibodies against clinically validated and novel targets; and MultiMab, an engineering platform that provides the flexibility to combine antibody building blocks in di… Read more
Market Cap & Net Worth: Abpro Holdings, Inc. (ABP)
Abpro Holdings, Inc. (NYSE:ABP) has a market capitalization of $18.33 Million ($18.33 Million) as of March 18, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #34276 globally and #11172 in its home market, demonstrating a 743.64% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Abpro Holdings, Inc.'s stock price $6.75 by its total outstanding shares 2716278 (2.72 Million).
Abpro Holdings, Inc. Market Cap History: 2022 to 2026
Abpro Holdings, Inc.'s market capitalization history from 2022 to 2026. Data shows change from $27.68 Million to $18.33 Million (-9.18% CAGR).
Index Memberships
Abpro Holdings, Inc. is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.24 Trillion | 0.00% | #860 of 976 |
Weight: Abpro Holdings, Inc.'s market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Abpro Holdings, Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Abpro Holdings, Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
25.92x
Abpro Holdings, Inc.'s market cap is 25.92 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $27.68 Million | $2.03 Million | -$17.21 Million | 13.64x | N/A |
| 2023 | $28.74 Million | $122.00K | -$11.71 Million | 235.56x | N/A |
| 2024 | $4.74 Million | $183.00K | -$7.23 Million | 25.92x | N/A |
Competitor Companies of ABP by Market Capitalization
Companies near Abpro Holdings, Inc. in the global market cap rankings as of March 18, 2026.
Key companies related to Abpro Holdings, Inc. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Abpro Holdings, Inc. Historical Marketcap From 2022 to 2026
Between 2022 and today, Abpro Holdings, Inc.'s market cap moved from $27.68 Million to $ 18.33 Million, with a yearly change of -9.18%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $18.33 Million | +59.57% |
| 2025 | $11.49 Million | +142.24% |
| 2024 | $4.74 Million | -83.50% |
| 2023 | $28.74 Million | +3.83% |
| 2022 | $27.68 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Abpro Holdings, Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $18.33 Million USD |
| MoneyControl | $18.33 Million USD |
| MarketWatch | $18.33 Million USD |
| marketcap.company | $18.33 Million USD |
| Reuters | $18.33 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.